Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
LFMD

LFMD - LifeMD, Inc. Stock Price, Fair Value and News

$3.39-0.11 (-3.14%)
Market Closed

80/100

LFMD

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

80/100

LFMD

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

$5.37

Target 3M

$4.08

Target 6M

$4.66

LFMD Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

LFMD Price Action

Last 7 days

-4.2%

Last 30 days

-1.5%

Last 90 days

-41.5%

Trailing 12 Months

-38.4%

LFMD RSI Chart

LFMD Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

LFMD Valuation

Market Cap

163.2M

Price/Earnings (Trailing)

-15.21

Price/Sales (Trailing)

0.65

EV/EBITDA

4.86

Price/Free Cashflow

15.26

LFMD Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

$5.37

Target 3M

$4.08

Target 6M

$4.66

LFMD Fundamentals

LFMD Revenue

Revenue (TTM)

252.3M

Rev. Growth (Yr)

12.7%

Rev. Growth (Qtr)

-3.29%

LFMD Earnings

Earnings (TTM)

-10.7M

Earnings Growth (Yr)

18.29%

Earnings Growth (Qtr)

-134.99%

LFMD Profitability

Operating Margin

86.96%

EBT Margin

10.19%

Return on Equity

-816.5%

Return on Assets

-16.26%

Free Cashflow Yield

6.55%

LFMD Investor Care

Shares Dilution (1Y)

11.14%

Diluted EPS (TTM)

-0.34

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
2025234.0M245.6M252.3M0
2024163.6M178.3M193.1M212.5M
2023123.1M128.6M135.8M152.5M
2022103.7M111.9M118.3M119.0M
202151.2M64.4M78.4M92.9M
202014.1M20.5M28.3M37.3M
20199.4M10.1M10.7M12.5M
20184.8M6.1M6.6M8.3M
20173.8M3.2M3.9M3.3M
20162.6M3.5M4.6M5.2M
2015810.0K890.7K1.0M1.2M
2014770.5K644.2K715.0K714.2K
2013725.5K820.8K763.4K808.4K
2012000673.8K
Get all data in R, Python etc through our Historical Stock Data APIs

About LifeMD, Inc.

LFMD
LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for care across various indications, including urgent and primary care, men's and women's health, and dermatology, chronic care management, and others in the United States. The company provides ShapiroMD, a telehealth platform brand that offers access to virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and food and drug administration approved medical device for male and female hair loss; RexMD, a men's telehealth brand that offers virtual medical treatment from licensed providers for a variety of men's health needs; LifeMD Primary Care, a virtual primary care platform that provides patients with primary care, urgent care, and chronic care needs, as well as offers a mobile first platform that incorporates virtual consultations and treatment, prescription medications, diagnostics, and imaging; Cleared, a telehealth brand that provides personalized treatments for allergy, asthma, and immunology; and NavaMD, a female-oriented and tele-dermatology brand that offers virtual medical treatment from dermatologists and other providers. It also offers PDFSimpli, an online software-as-a-service platform that allows users to create, edit, convert, sign, and share PDF documents. The company sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was founded in 1994 and is headquartered in New York, New York.
 CEO
 WEBSITEhttps://lifemd.com
 SECTORHealthcare
 INDUSTRYHealth Information Services
 EMPLOYEES199

LifeMD, Inc. Frequently Asked Questions

LFMD is the stock ticker symbol of LifeMD, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

As of Wed Jan 28 2026, market cap of LifeMD, Inc. is 163.18 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

You can check LFMD's fair value in chart for subscribers.

The fair value guage provides a quick view whether LFMD is over valued or under valued. Whether LifeMD, Inc. is cheap or expensive depends on the assumptions which impact LifeMD, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for LFMD.

As of Wed Jan 28 2026, LFMD's PE ratio (Price to Earnings) is -15.21 and Price to Sales (PS) ratio is 0.65. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. LFMD PE ratio will change depending on the future growth rate expectations of investors.

In the past 10 years, LifeMD, Inc. has provided 0.163 (multiply by 100 for percentage) rate of return.